This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 28 Apr 2017  |  Global  |  Technology Alert

    Innovations in Biomedical Imaging

    The latest issue of Medical and Diagnostic Imaging TOE profiles innovations in biomedical imaging. Some of the profiles covered include magnetic resonance imaging (MRI) for targeted drug delivery, computerized blood flow simulation with MRI scans, next-generation contrast agents, upper extremity MRI modality, tablet-controlled computed tomography s...

    $950.00
  2. 28 Apr 2017  |  Global  |  Technology Alert

    Advancements across Skin Testing Sector

    This Genetic Technology TOE depicts trends across the skin testing sector. Technology profiles for skin mimicking, tissue models, in vitro testing and tissue engineering approaches are presented. Clinical trials scenario for skin irritation testing is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engi...

    $250.00
  3. The latest issue of the Medical Devices TOE profiles eight innovations spanning the breadth of the MedTech space. These include synthetic surgical adhesives and sealants, non-invasive biomarker analysis for early cancer detection, borate-based bioactive wound dressing, a nanoscale glass for lab-on-a-chip devices, and a wrist worn wearable and healt...

    $950.00
  4. 21 Apr 2017  |  Global  |  Technology Alert

    Advances in Liquid Biopsy Platforms

    This Genetic Technology TOE depicts trends across liquid biopsy platforms. The advent of novel antibody-based and targeted small molecule therapies have greatly improved the management of cancer disease. However, there is a growing need for robust monitoring platforms for enhanced assessment of diseases progression and treatment monitoring in cance...

    $250.00
  5. 20 Apr 2017  |  Asia Pacific  |  Market Research

    The Philippines Transformational Healthcare Insights, 2016

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...

    $1,500.00
  6. 14 Apr 2017  |  Global  |  Technology Alert

    Robotics in Drug Discovery

    The introduction of automation and robotics into the drug discovery process has greatly enhanced the ability to explore and identify new drug candidates. Numerous chemical compounds can be manufactured and analyzed in a matter of a couple of weeks. Robotics can run tests on thousands of these compounds on biological samples for potential therapeuti...

    $950.00
  7. 14 Apr 2017  |  Global  |  Technology Alert

    Advancements across Life Science Sector

    This Genetic Technology TOE depicts the current landscape across life sciences sector. 3D tissue microenvironment tests, protein-based drugs manufacturing, skin testing, cosmetics developments, and crowdsourcing for clinical trials are profiled. The corresponding industry interactions are also depicted. The Genetic Technology TechVision Opportunit...

    $250.00
  8. 07 Apr 2017  |  Global  |  Technology Alert

    Recent Advances in Biopharmaceutical Technologies

    This Genetic Technology TOE profiles recent trends across biopharmaceutical technologies. The corresponding clinical trials are also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive fie...

    $250.00
  9. 31 Mar 2017  |  Global  |  Technology Alert

    Recent FDA-approved Therapeutics

    This Genetic Technology TOE profiles therapeutics that have been recently approved by FDA. The corresponding clinical trials scenario is also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the exp...

    $250.00
  10. 29 Mar 2017  |  Europe  |  Mega Trends

    Biosimilars Market, Europe, Forecast to 2025

    A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter

    Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

    $4,950.00